全文获取类型
收费全文 | 4056114篇 |
免费 | 291317篇 |
国内免费 | 8321篇 |
专业分类
耳鼻咽喉 | 58272篇 |
儿科学 | 128680篇 |
妇产科学 | 110305篇 |
基础医学 | 564162篇 |
口腔科学 | 120561篇 |
临床医学 | 361873篇 |
内科学 | 776164篇 |
皮肤病学 | 85609篇 |
神经病学 | 334275篇 |
特种医学 | 159536篇 |
外国民族医学 | 1499篇 |
外科学 | 610967篇 |
综合类 | 95552篇 |
现状与发展 | 7篇 |
一般理论 | 1695篇 |
预防医学 | 328135篇 |
眼科学 | 96302篇 |
药学 | 298424篇 |
10篇 | |
中国医学 | 8638篇 |
肿瘤学 | 215086篇 |
出版年
2018年 | 59985篇 |
2017年 | 46528篇 |
2016年 | 52111篇 |
2015年 | 40525篇 |
2014年 | 57217篇 |
2013年 | 86433篇 |
2012年 | 120837篇 |
2011年 | 139731篇 |
2010年 | 87172篇 |
2009年 | 77959篇 |
2008年 | 130851篇 |
2007年 | 141061篇 |
2006年 | 122922篇 |
2005年 | 121654篇 |
2004年 | 118640篇 |
2003年 | 115491篇 |
2002年 | 110440篇 |
2001年 | 172439篇 |
2000年 | 178043篇 |
1999年 | 150901篇 |
1998年 | 44571篇 |
1997年 | 40240篇 |
1996年 | 39015篇 |
1995年 | 37671篇 |
1994年 | 35344篇 |
1993年 | 32877篇 |
1992年 | 120684篇 |
1991年 | 117134篇 |
1990年 | 113986篇 |
1989年 | 110418篇 |
1988年 | 102162篇 |
1987年 | 100983篇 |
1986年 | 96000篇 |
1985年 | 92075篇 |
1984年 | 69756篇 |
1983年 | 59519篇 |
1982年 | 36273篇 |
1981年 | 32498篇 |
1979年 | 66241篇 |
1978年 | 47019篇 |
1977年 | 40215篇 |
1976年 | 37392篇 |
1975年 | 40409篇 |
1974年 | 49142篇 |
1973年 | 47172篇 |
1972年 | 44530篇 |
1971年 | 41622篇 |
1970年 | 39217篇 |
1969年 | 36893篇 |
1968年 | 33975篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
981.
Donor interleukin-4 promoter gene polymorphism influences allograft rejection after heart transplantation. 总被引:3,自引:0,他引:3
Femke J Bijlsma Joyce vanKuik Marcel G J Tilanus Nicolaas deJonge Erik H Rozemuller Jan G van den Tweel Frits H J Gmelig-Meyling Roel A deWeger 《The Journal of heart and lung transplantation》2002,21(3):340-346
BACKGROUND: The cytokine interleukin-4 (IL-4) is secreted mainly by activated T lymphocytes and characterizes the T-helper 2 (Th2) sub-type. In transplantation Th2 cells are believed to induce graft tolerance. Previous studies revealed that patients with a relatively high frequency of IL-4 producing helper T lymphocytes (HTL) before heart transplantation (HTX) had no or less rejection episodes compared with patients with a low frequency of IL-4 producing HTL. Three single nucleotide polymorphisms (SNPs) have been identified in the promoter region of the IL-4 gene, which influence promoter strength. We investigated whether there was a correlation between SNP genotypes in the IL-4 promoter and heart failure, and rejection after HTX. METHODS: Seventy HTX patients, 61 donors, and 36 controls were genotyped for the 3 SNPs by sequencing. RESULTS: Of the SNPs at -285 and -81, only the C and A alleles, respectively, were found in this study. Both alleles were found for the -590 SNP. No relation between patient genotype of the SNP at -590 and heart failure and rejection was found. However, incidence of rejection was significantly lower in patients that received a donor heart with the T-positive genotype compared with patients that received a heart from a T-negative donor. Patients who had the T-negative genotype and received a heart from a T-positive donor, suffered significantly less from rejection than T-negative patients that received a T-negative donor heart. This was not significant in the T-positive patient group. CONCLUSIONS: This indicates that IL-4 production within the donor heart and by cells from the donor is important for reducing incidence of episodes of rejection. 相似文献
982.
983.
984.
Ignacio Lopez Escolastico Aguilera-Tejero Arnold J Felsenfeld Jose Carlos Estepa Mariano Rodriguez 《Journal of bone and mineral research》2002,17(9):1691-1700
Because both metabolic (Met Acid) and respiratory acidosis (Resp Acid) have diverse effects on mineral metabolism, it has been difficult to establish whether acidosis directly affects parathyroid hormone (PTH) secretion. Our goal was to determine whether acute Met Acid and Resp Acid directly affected PTH secretion. Three groups of dogs were studied: control, acute Met Acid induced by HCl infusion, and acute Resp Acid induced by hypoventilation. EDTA was infused to prevent acidosis-induced increases in ionized calcium, but more EDTA was needed in Met Acid than in Resp Acid. The PTH response to EDTA-induced hypocalcemia was evaluated also. Magnesium needed to be infused in groups receiving EDTA to prevent hypomagnesemia. The half-life of intact PTH (iPTH) was determined during hypocalcemia when PTH was measured after parathyroidectomy. During normocalcemia, PTH values were greater (p < 0.05) in Met Acid (92 +/- 19 pg/ml) and Resp Acid (77 +/- 22 pg/ml) than in controls (27 +/- 5 pg/ml); the respective pH values were 7.23 +/- 0.01, 7.24 +/- 0.01, and 7.39 +/- 0.02. The maximal PTH response to hypocalcemia was greater (p < 0.05) in Met Acid (443 +/- 54 pg/ml) than in Resp Acid (267 +/- 37 pg/ml) and controls (262 +/- 48 pg/ml). The half-life of PTH was greater (p < 0.05) in Met Acid than in controls, but the PTH secretion rate also was greater (p < 0.05) in Met Acid than in the other two groups. In conclusion, (1) both acute Met Acid and Resp Acid increase PTH secretion when the ionized calcium concentration is normal; (2) acute Met Acid may increase the bone efflux of calcium more than Resp Acid; (3) acute Met Acid acts as a secretogogue for PTH secretion because it enhances the maximal PTH response to hypocalcemia. 相似文献
985.
The triphalangeal thumb-brachyectrodactyly syndrome is a very rare autosomal dominant disorder of unknown etiology characterized by an unusual pattern of limb malformations: triphalangeal thumbs and brachyectrodactyly in the hands, and ectrodactyly in the feet. In a previous report, we described the clinical and radiographical features of three related subjects with the disease and suggest that due to the unusual combination of limb defects and to its phenotypic similarity with the limb malformative pattern induced by disrupting the Hoxd13 gene in mouse, the triphalangeal thumb-brachyectrodactyly syndrome might be caused by mutations in a HOX gene. After sequencing the entire coding region of HOXD13 and the highly conserved homeodomain encoding region of HOXA13, we do not detect any deleterious mutation in any of the patients excluding that alterations at these sequences are responsible for the disease. Mutations in regulatory regions of these genes or in other genes involved in limb development might be responsible for the disease. 相似文献
986.
987.
H. Draper 《Journal of Renal Care》2002,28(Z2):39-42
The majority of patients being treated for acute renal failure in intensive care units have multiple medical problems. Accordingly, the withdrawal of renal replacement therapies should be considered as part of a general decision about whether to initiate or continue with treatment per se. Several guidelines on withdrawing and withholding therapy have been produced and some common themes emerge: concerns to avoid euthanasia, potential for benefit, patient consent (shared decision‐making), team consensus/decision‐making, and the provision of appropriate palliative care and resource implications. Each of these is considered in turn, although the word limit for this paper does not permit detailed exposition. 相似文献
988.
C. Sch?fer H. H. Klünemann B. Ibach J. Mueller A. Putzhammer I. Trender-Gerhard G. Schuierer H. E. Klein 《Der Nervenarzt》2002,24(1):879-882
Wir berichten über den ersten Fall von polyzystischer lipomembran?ser Osteodysplasie oder “brain, bone and fat disease” in
Deutschland. Die nach dem Erstbeschreibern auch als Morbus J?rvi-Hakola-Nasu bezeichnete Erkrankung ist bisher vor allem in
Japan und in Finnland beschrieben worden. Einzelne F?lle wurden aus Schweden, Norwegen, Italien, Südafrika, Belgien und den
USA berichtet. Im deutschsprachigen Raum ist bisher ein Fall aus ? ver?ffentlicht worden. 相似文献
989.
990.
The authors report the association of erythroleukemia (FAB M6) and fetal hemoglobin (HbF) level of at least 65% after therapy for ovarian carcinoma. The patient's erythrocytes had many signs of reversion to fetal-like erythropoiesis including: elevated HbF with a fetal G gamma/A gamma (gly/ala) of 3/1, low hemoglobin A2 (HbA2), macrocytosis, and increased i antigen. These data and data from other case reports suggest that elevation of HbF to greater than 25% with reversion to fetal-like erythropoiesis is useful in differentiating erythroleukemia from other preleukemic disorders. 相似文献